메뉴 건너뛰기




Volumn 6, Issue 32, 2015, Pages 33961-33971

Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: A meta-analysis

Author keywords

B cell malignancies; CD19; Chimeric antigen receptor; Efficiency; Meta analysis

Indexed keywords

CD19 ANTIGEN; CHIMERIC ANTIGEN RECEPTOR; CYCLOPHOSPHAMIDE; FLUDARABINE; INTERLEUKIN 2; PENTOSTATIN; LYMPHOCYTE ANTIGEN RECEPTOR;

EID: 84946040235     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5582     Document Type: Article
Times cited : (107)

References (42)
  • 1
    • 84899631361 scopus 로고    scopus 로고
    • Antibodymodified T cells: CARs take the front seat for hematologic malignancies
    • Maus MV, Grupp SA, Porter DL, June CH. Antibodymodified T cells: CARs take the front seat for hematologic malignancies. Blood. 2014;123:2625-35.
    • (2014) Blood , vol.123 , pp. 2625-2635
    • Maus, M.V.1    Grupp, S.A.2    Porter, D.L.3    June, C.H.4
  • 5
    • 80051720194 scopus 로고    scopus 로고
    • Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia
    • Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365:725-33.
    • (2011) N Engl J Med , vol.365 , pp. 725-733
    • Porter, D.L.1    Levine, B.L.2    Kalos, M.3    Bagg, A.4    June, C.H.5
  • 6
    • 80051775476 scopus 로고    scopus 로고
    • T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia
    • Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med. 2011;3:95ra73.
    • (2011) Sci Transl Med , vol.3
    • Kalos, M.1    Levine, B.L.2    Porter, D.L.3    Katz, S.4    Grupp, S.A.5    Bagg, A.6    June, C.H.7
  • 9
    • 77955510549 scopus 로고    scopus 로고
    • Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans
    • Jensen MC, Popplewell L, Cooper LJ, DiGiusto D, Kalos M, Ostberg JR, Forman SJ. Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans. Biol Blood Marrow Transplant 2010;16:1245-56.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 1245-1256
    • Jensen, M.C.1    Popplewell, L.2    Cooper, L.J.3    DiGiusto, D.4    Kalos, M.5    Ostberg, J.R.6    Forman, S.J.7
  • 17
    • 0023864495 scopus 로고
    • Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins
    • Uckun FM, Jaszcz W, Ambrus JL, Fauci AS, Gajl-Peczalska K, Song CW, Wick MR, Myers DE, Waddick K, Ledbetter JA. Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood. 1988;71:13-29.
    • (1988) Blood , vol.71 , pp. 13-29
    • Uckun, F.M.1    Jaszcz, W.2    Ambrus, J.L.3    Fauci, A.S.4    Gajl-Peczalska, K.5    Song, C.W.6    Wick, M.R.7    Myers, D.E.8    Waddick, K.9    Ledbetter, J.A.10
  • 18
    • 84872027520 scopus 로고    scopus 로고
    • Efficacy and safety of adoptive immunotherapy using anti-CD19 chimeric antigen receptor transduced T-cells: a systematic review of phase I clinical trials
    • Xu XJ, Zhao HZ, Tang YM. Efficacy and safety of adoptive immunotherapy using anti-CD19 chimeric antigen receptor transduced T-cells: a systematic review of phase I clinical trials. Leuk Lymphoma. 2013;54:255-60.
    • (2013) Leuk Lymphoma , vol.54 , pp. 255-260
    • Xu, X.J.1    Zhao, H.Z.2    Tang, Y.M.3
  • 19
    • 84874053507 scopus 로고    scopus 로고
    • The myth of the second remission of acute leukemia in the adult
    • Forman SJ, Rowe JM. The myth of the second remission of acute leukemia in the adult. Blood. 2013;121:1077-82.
    • (2013) Blood , vol.121 , pp. 1077-1082
    • Forman, S.J.1    Rowe, J.M.2
  • 22
    • 79953814653 scopus 로고    scopus 로고
    • Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL
    • Christopoulos P, Pfeifer D, Bartholome K, Follo M, Timmer J, Fisch P, Veelken H. Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL. Blood. 2011;117:3836-46.
    • (2011) Blood , vol.117 , pp. 3836-3846
    • Christopoulos, P.1    Pfeifer, D.2    Bartholome, K.3    Follo, M.4    Timmer, J.5    Fisch, P.6    Veelken, H.7
  • 23
    • 84875787670 scopus 로고    scopus 로고
    • Understanding the immunodeficiency in chronic lymphocytic leukemia: potential clinical implications
    • Riches JC, Gribben JG. Understanding the immunodeficiency in chronic lymphocytic leukemia: potential clinical implications. Hematol Oncol Clin North Am. 2013;27:207-35.
    • (2013) Hematol Oncol Clin North Am , vol.27 , pp. 207-235
    • Riches, J.C.1    Gribben, J.G.2
  • 24
    • 70350734809 scopus 로고    scopus 로고
    • The microenvironment in mature B-cell malignancies: a target for new treatment strategies
    • Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood. 2009;114:3367-75.
    • (2009) Blood , vol.114 , pp. 3367-3375
    • Burger, J.A.1    Ghia, P.2    Rosenwald, A.3    Caligaris-Cappio, F.4
  • 26
    • 79955030135 scopus 로고    scopus 로고
    • Adolescents and young adults with acute lymphoblastic leukemia
    • Stock W. Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2010;2010:21-9.
    • (2010) Hematology Am Soc Hematol Educ Program , vol.2010 , pp. 21-29
    • Stock, W.1
  • 28
    • 70449726875 scopus 로고    scopus 로고
    • Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
    • Cui Y, Zhang H, Meadors J, Poon R, Guimond M, Mackall CL. Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts. Blood. 2009;114:3831-40.
    • (2009) Blood , vol.114 , pp. 3831-3840
    • Cui, Y.1    Zhang, H.2    Meadors, J.3    Poon, R.4    Guimond, M.5    Mackall, C.L.6
  • 30
    • 84877669593 scopus 로고    scopus 로고
    • The basic principles of chimeric antigen receptor design
    • Sadelain M, Brentjens R, Rivière I. The basic principles of chimeric antigen receptor design. Cancer Discov. 2013;3:388-98.
    • (2013) Cancer Discov , vol.3 , pp. 388-398
    • Sadelain, M.1    Brentjens, R.2    Rivière, I.3
  • 31
    • 0036170440 scopus 로고    scopus 로고
    • Activation and inhibition of lymphocytes by costimulation
    • Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest. 2002;109:295-9.
    • (2002) J Clin Invest , vol.109 , pp. 295-299
    • Frauwirth, K.A.1    Thompson, C.B.2
  • 32
    • 0033567945 scopus 로고    scopus 로고
    • The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death
    • Dai Z, Arakelov A, Wagener M, Konieczny BT, Lakkis FG. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death. J Immunol. 1999;163:3131-7.
    • (1999) J Immunol , vol.163 , pp. 3131-3137
    • Dai, Z.1    Arakelov, A.2    Wagener, M.3    Konieczny, B.T.4    Lakkis, F.G.5
  • 33
    • 2542595794 scopus 로고    scopus 로고
    • IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21
    • Moroz A, Eppolito C, Li Q, Tao J, Clegg CH, Shrikant PA. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J Immunol. 2004;173:900-9.
    • (2004) J Immunol , vol.173 , pp. 900-909
    • Moroz, A.1    Eppolito, C.2    Li, Q.3    Tao, J.4    Clegg, C.H.5    Shrikant, P.A.6
  • 34
    • 77958137842 scopus 로고    scopus 로고
    • Comparison of anti-CD3 and antiCD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation
    • Li Y, Kurlander RJ. Comparison of anti-CD3 and antiCD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation. J Transl Med. 2010;8:104.
    • (2010) J Transl Med , vol.8 , pp. 104
    • Li, Y.1    Kurlander, R.J.2
  • 35
    • 84908700977 scopus 로고    scopus 로고
    • The inducible caspase-9 suicide gene system as a "safety switch" to limit on-target, offtumor toxicities of chimeric antigen receptor T cells
    • Gargett T, Brown MP. The inducible caspase-9 suicide gene system as a "safety switch" to limit on-target, offtumor toxicities of chimeric antigen receptor T cells. Front Pharmaco. 2014;5:235.
    • (2014) Front Pharmaco , vol.5 , pp. 235
    • Gargett, T.1    Brown, M.P.2
  • 36
    • 84872196489 scopus 로고    scopus 로고
    • Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
    • Kloss CC, Condomines M, Cartellieri M, Bachmann M, Sadelain M. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells. Nat Biotechno. 2013;31:71-5.
    • (2013) Nat Biotechno , vol.31 , pp. 71-75
    • Kloss, C.C.1    Condomines, M.2    Cartellieri, M.3    Bachmann, M.4    Sadelain, M.5
  • 38
    • 84858759305 scopus 로고    scopus 로고
    • Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
    • Pegram HJ, Lee JC, Hayman EG, Imperato GH, Tedder TF, Sadelain M, Brentjens RJ. Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood. 2012;119:4133-41.
    • (2012) Blood , vol.119 , pp. 4133-4141
    • Pegram, H.J.1    Lee, J.C.2    Hayman, E.G.3    Imperato, G.H.4    Tedder, T.F.5    Sadelain, M.6    Brentjens, R.J.7
  • 39
    • 84875463042 scopus 로고    scopus 로고
    • Molecular mechanisms of T cell co-stimulation and co-inhibition
    • Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13:227-42.
    • (2013) Nat Rev Immunol , vol.13 , pp. 227-242
    • Chen, L.1    Flies, D.B.2
  • 40
    • 84858766182 scopus 로고    scopus 로고
    • The blockade of immune checkpoints in cancer immunotherapy
    • Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252-64.
    • (2012) Nat Rev Cancer , vol.12 , pp. 252-264
    • Pardoll, D.M.1
  • 41
    • 85100415918 scopus 로고    scopus 로고
    • Cochrane handbook for systematic reviews of interventions, 5th edn
    • Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions, 5th edn. The Cochrane Collaboration, 2011.
    • (2011) The Cochrane Collaboration
    • Higgins, J.P.T.1    Green, S.2
  • 42
    • 84971529363 scopus 로고    scopus 로고
    • Metaprop: a Stata command to perform meta-analysis of binomial data
    • Victoria N, Marc A, Marc A. Metaprop: a Stata command to perform meta-analysis of binomial data. Archives of Public Health. 2014;72:39.
    • (2014) Archives of Public Health , vol.72 , pp. 39
    • Victoria, N.1    Marc, A.2    Marc, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.